Cochrane Abstracts
20 µg versus >20 µg estrogen combined oral contraceptives for contraception
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"20 Μg Versus >20 Μg Estrogen Combined Oral Contraceptives for Contraception." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435019/all/20_µg_versus_>.
20 µg versus >20 µg estrogen combined oral contraceptives for contraception. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435019/all/20_µg_versus_>. Accessed April 18, 2026.
20 µg versus >20 µg estrogen combined oral contraceptives for contraception. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435019/all/20_µg_versus_>
20 Μg Versus >20 Μg Estrogen Combined Oral Contraceptives for Contraception [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 April 18]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435019/all/20_µg_versus_>.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - 20 µg versus >20 µg estrogen combined oral contraceptives for contraception
ID - 435019
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435019/all/20_µg_versus_>
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
